Fulvestrant Injection

Fulvestrant Injection

Categories : Oncology

Product Packaging : PFS

Product Composition : 250mg/5ml (PFS)

Send Message

Fulvestrant Injection is a hormonal anticancer medication used for the treatment of hormone receptor-positive advanced or metastatic breast cancer in postmenopausal women. It works by binding to estrogen receptors and blocking their activity, thereby slowing the growth and progression of hormone-sensitive cancer cells. Genliva Wellness LLP is a trusted Fulvestrant Injection Manufacturer in India offering high-quality oncology formulations for domestic and international pharmaceutical markets.

This injectable formulation is widely prescribed for patients with advanced breast cancer, particularly when disease progression occurs following prior hormonal therapy. As a reliable Fulvestrant Injection Exporter from India, Genliva Wellness LLP supplies quality-assured oncology products to healthcare providers and pharmaceutical distributors worldwide.

Fulvestrant is an important endocrine therapy option in breast cancer management and plays a significant role in improving treatment outcomes for patients with hormone receptor-positive disease.

Fulvestrant Injection is formulated to provide targeted hormonal therapy for hormone-sensitive breast cancer.

  • Contains Fulvestrant as the active ingredient
  • Selective estrogen receptor degrader (SERD)
  • Blocks and degrades estrogen receptors
  • Hormonal treatment for breast cancer
  • Long-acting injectable formulation
  • Designed for intramuscular administration

Fulvestrant Injection is used in the treatment of hormone receptor-positive breast cancer.

  • Advanced breast cancer
  • Metastatic breast cancer
  • Hormone receptor-positive breast cancer
  • Postmenopausal breast cancer management
  • Endocrine therapy for breast cancer
  • Treatment following progression on hormonal therapy

Fulvestrant Injection offers targeted hormonal therapy for effective breast cancer management.

  • Reduces estrogen receptor activity
  • Helps slow cancer progression
  • Targets hormone-sensitive cancer cells
  • Supports long-term disease management
  • Provides an alternative to other endocrine therapies
  • Contributes to improved treatment response

whatsapp-app